Download or read book Driving Innovation and Job Growth Through the Life Sciences Industry written by Congress of the United States and published by . This book was released on 2012-06-21 with total page 56 pages. Available in PDF, EPUB and Kindle. Book excerpt: We are going to examine today the key roles that are played by the life sciences, and life sciences companies in driving innovation and job creation throughout our country. We hope to shine light on the opportunities created by this vibrant sector and explore new policy actions that can incentivize additional research and development in the life sciences industry, and have a broader conversation about the role the Federal Government plays in supporting R&D.
Download or read book Driving Innovation and Job Growth Through the Life Sciences Industry written by United States. Congress. Joint Economic Committee and published by . This book was released on 2011 with total page 60 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Driving Innovation and Job Growth Through the Life Sciences Industry S Hrg 112 75 May 25 2011 112 1 Hearing written by United States. Congress. Joint Economic Committee and published by . This book was released on 2011* with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Driving Innovation and Job Growth Through the Life Sciences Industry written by United States. Congress. Joint Economic Committee and published by . This book was released on 2011 with total page 51 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Managing Discovery in the Life Sciences written by Philip A. Rea and published by Cambridge University Press. This book was released on 2018-02 with total page 557 pages. Available in PDF, EPUB and Kindle. Book excerpt: Addresses in roughly equal measure the science and management behind several recent marketable biomedical innovations.
Download or read book The New Players in Life Science Innovation written by Tomasz Mroczkowski and published by Pearson Education. This book was released on 2011-07-07 with total page 354 pages. Available in PDF, EPUB and Kindle. Book excerpt: The global center of gravity in life sciences innovation is rapidly shifting to emerging economies. In The New Players in Life Science Innovation, Tomasz Mroczkowski explains how China and other new economic powers are rapidly gaining leadership positions, and thoroughly assesses the implications. Mroczkowski discusses the sophisticated innovation strategies and reforms these nations have implemented: approaches that don't rely on market forces alone, and are achieving remarkable success. Next, he previews the emerging global "bio-economy," in which life science discoveries will be applied pervasively in markets ranging from health to fuels. As R&D in the West becomes increasingly costly, Mroczkowski introduces new options for partnering with new players in the field. He thoroughly covers the globalization of clinical trials, showing how it offers opportunities that go far beyond cost reduction, and assessing the unique challenges it presents. Offering examples from China to Dubai to India, he carefully assesses the business models driving today's newest centers of innovation. Readers will find up-to-date coverage of bioparks, technology zones, and emerging clusters, and realistic assessments of global R&D collaboration strategies such as those of Eli Lilly, Merck, Novartis, and IBM. With innovation-driven industries increasingly dominating the global economy, this book's insights are indispensable for every R&D decision-maker and investor.
Download or read book Innovation Commercialization and Start Ups in Life Sciences written by James F. Jordan and published by CRC Press. This book was released on 2014-11-05 with total page 260 pages. Available in PDF, EPUB and Kindle. Book excerpt: Innovation is the translation of a new method, idea, or product into reality and profit. It is a process of connected steps that accumulates into your brand or reputation. However, there can be many pitfalls and wrong turns on the road to realizing this goal. Innovation, Commercialization, and Start-Ups in Life Sciences details the methodologies ne
Download or read book Business Modeling for Life Science and Biotech Companies written by Alberto Onetti and published by Routledge. This book was released on 2014-03-21 with total page 212 pages. Available in PDF, EPUB and Kindle. Book excerpt: Most books on the biotechnology industry focus on scientific and technological challenges, ignoring the entrepreneurial and managerial complexities faced bio-entrepreneurs. The Business Models for Life Science Firms aims to fill this gap by offering managers in this rapid growth industry the tools needed to design and implement an effective business model customized for the unique needs of research intensive organizations. Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and strategy: focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization’s activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.
Download or read book Managing Biotechnology written by Francoise Simon and published by John Wiley & Sons. This book was released on 2017-10-16 with total page 322 pages. Available in PDF, EPUB and Kindle. Book excerpt: A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma industry continues to grow and expand its reach, development costs are colliding with aging demographics and cost-containment policies of private and public payers. Concurrently, the development and increased affordability of sophisticated digital technologies has fundamentally altered many industries including healthcare. The arrival of new information technology (infotech) companies on the healthcare scene presents both opportunities and challenges for the biopharma business model. To capitalize on new digital technologies from R&D through commercialization requires industry leaders to adopt new business models, develop new digital and data capabilities, and partner with innovators and payers worldwide. Written by two experts, both of whom have had decades of experience in the field, this book provides a comprehensive overview of the new business context and marketing models for biotech companies. Informed by extensive input by senior biotech executives and leading consultancies serving the industry, it analyzes the strategies and key success factors for the financing, development, and commercialization of novel therapeutic products, including strategies for engagement with patients, physicians and healthcare payers. Throughout case studies provide researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals involved in the biotech sector with insights, ideas, and models. JACQUALYN FOUSE, PhD, RETIRED PRESIDENT AND CHIEF OPERATING OFFICER, CELGENE “Biotech companies have long been innovators, using the latest technologies to enable cutting edge science to help patients with serious diseases. This book is essential to help biotech firms understand how they can–and must–apply the newest technologies including disruptive ones, alongside science, to innovate and bring new value to the healthcare system.” BRUCE DARROW, MD, PhD, CHIEF MEDICAL INFORMATION OFFICER, MOUNT SINAI HEALTH SYSTEM “Simon and Giovannetti have written an essential user’s manual explaining the complicated interplay of the patients who deserve cutting-edge medical care, the biotechnology companies (big and small) creating the breakthroughs, and the healthcare organizations and clinicians who bridge those worlds.” EMMANUEL BLIN, FORMER CHIEF STRATEGY OFFICER AND SENIOR VICE PRESIDENT, BRISTOL-MYERS SQUIBB “If you want to know where biopharma is going, read this book! Our industry is facing unprecedented opportunities driven by major scientific breakthroughs, while transforming itself to address accelerated landscape changes driven by digital revolutions and the emergence of value-based healthcare worldwide. In this ever-changing context, we all need to focus everything we do on the patients. They are why we exist as an industry, and this is ultimately what this insightful essay is really about.” JOHN MARAGANORE, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ALNYLAM PHARMACEUTICALS “Since the mapping of the human genome was completed nearly 15 years ago, the biotechnology industry has led the rapid translation of raw science to today’s innovative medicines. However, the work does not stop in the lab. Delivering these novel medicines to patients is a complex and multifaceted process, which is elegantly described in this new book.”
Download or read book Redefining Innovation written by Ruchin Kansal and published by Taylor & Francis. This book was released on 2018-05-11 with total page 199 pages. Available in PDF, EPUB and Kindle. Book excerpt: Most people marvel at the level of innovation demonstrated by the biopharmaceutical industry in bringing new products to the market – especially in the past 20 years. However, there is a crisis looming in the industry that should be a concern to all of us who take for granted the constant pace at which new treatments, and increasingly cures, have emerged from the laboratories of current sector incumbents. In the book, we examine the evolution of the biopharmaceutical industry to understand how it became what we term a "unicorn industry" with a unique, US-centered business model that has led to multiple blockbuster products (aka, unicorns) year after year. We explore how past success has created perceived barriers to innovation diversification beyond the chemical or biological-based biopharmaceutical product, and highlight the warning signs of the industry’s decline. We define a potential pathway for transforming the industry’s business model by broadening the definition, sources, and enablers of innovation beyond the traditional biopharmaceutical product. We introduce and advocate for the 80-80 Rule - "Being 80% confident that you will only be 80% right the first time should feel normal." The 80-80 Rule is a theme that emphasizes speed and willingness to embrace uncertainty and overcome internal barriers to change. It sets the standard for redefining innovation as a platform to reignite growth of the biopharmaceutical industry.
Download or read book Innovation in the Biopharmaceutical Industry written by Rifat A. Atun and published by World Scientific. This book was released on 2007 with total page 153 pages. Available in PDF, EPUB and Kindle. Book excerpt: Innovation is at the heart of all advances and has the capacity to solve problems facing humanity. Societies which have turned away from innovation and technological development have failed in their ability to support their populations. Understanding the nature of innovation in the life sciences and in particular healthcare, how it operates, what enables and hinders it is therefore of great importance to meeting the challenges ahead. This book, originally and concurrently published in the International Journal of Innovation Management, Vol. 11, No. 2, 2007, offers the latest research and insights concerning innovation in the biopharmaceutical industry.
Download or read book Science Technology and Industry Outlook 2001 Drivers of Growth Information Technology Innovation and Entrepreneurship written by OECD and published by OECD Publishing. This book was released on 2001-09-17 with total page 126 pages. Available in PDF, EPUB and Kindle. Book excerpt: The impact of information technology, innovation and entrepreneurship on economic performance is the subject of heated debate. This special edition of the Science, Technology and Industry Outlook takes a closer look at the ways in which these factors are evolving and how they relate to each other.
Download or read book Innovation and Industrial Leadership written by Fabio Pammolli and published by Thomas Rid. This book was released on 2007 with total page 240 pages. Available in PDF, EPUB and Kindle. Book excerpt: Bioscience is a critical innovation driver across many economic sectors and a key bellwether of European, North American, and Asian competitiveness. In this volume, two leading scholars examine the competitive position and performance of pharmaceutical companies and industries in Europe, North America, and Japan, as well as China, India, and other emergent economies. Innovation and Industrial Leadership is the most comprehensive and up-to-date analysis available of the global pharmaceutical industry. Pammolli and Riccaboni explain the strengths and weaknesses of the pharmaceutical markets in major global markets. They examine market share and market size, compare employment and productivity levels, look at innovation trends and the international migration of talent, and examine the globalization strategies of leading companies and nations. The authors compare U.S. and European innovation systems and trace how China and India are accumulating scientific and technological capabilities in the life sciences and in pharmaceuticals. The book reveals that Europe is lagging behind the U.S. in its ability to generate, organize, and sustain innovation processes in pharmaceuticals and resulting productivity growth. The authors advance a concrete agenda for Europe to regain competitiveness and call for renewed transatlantic dialogue on the political economy of the pharmaceutical industry, on trade policy, and on protection of intellectual property rights.
Download or read book The Impact of Innovation and the Role of IP Rights on U S Productivity Competitiveness Jobs Wages and Exports written by Nam Pham and published by . This book was released on 2017 with total page 75 pages. Available in PDF, EPUB and Kindle. Book excerpt: Intellectual property rights and innovation are primary drivers of job creation and American economic growth. IP-intensive industries -- such as life sciences, software, and aerospace -- are succeeding globally, driving innovation, and investing heavily in research and development; this in turn grows the economy by creating jobs and driving exports in a variety of different careers and trades.
Download or read book Driving American Innovation written by United States. Congress. House. Committee on the Judiciary. Subcommittee on Intellectual Property, Competition, and the Internet and published by . This book was released on 2011 with total page 62 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Driving Growth Through Innovation EasyRead Edition written by Robert B. Tucker and published by ReadHowYouWant.com. This book was released on 2002 with total page 350 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Darwin s Medicine written by Brian D. Smith and published by Routledge. This book was released on 2016-10-14 with total page 349 pages. Available in PDF, EPUB and Kindle. Book excerpt: Darwin’s Medicine is the sequel to Brian D. Smith’s influential and critically acclaimed Future of Pharma (Gower, 2011). Whereas the earlier book predicted the evolution of the pharmaceutical market and the business models of pharmaceutical companies, Darwin’s Medicine goes much deeper into the drivers of industry change and how leading pharmaceutical and medical technology companies are adapting their strategies, structures and capabilities in practice. Through the lens of evolutionary science, Professor Smith explores the speciation of new business models in the Life Sciences Industry. This sophisticated and highly original approach offers insights into: The mechanisms of evolution in this exceptional industry; The six great technological and social shifts that are shaping its landscape; The emergence of 26 distinct, new business models; and The lessons that enable firms to direct and accelerate their own evolution. These insights map out the industry’s complex, changing landscape and provide an invaluable guide to those firms seeking to survive and thrive in this dynamic market. The book is essential reading for anyone working in or studying the pharmaceutical, medical technology and related sectors. It provides a unique and novel way of making sense of the transformation we can see going on around us and a practical, focused approach to managing a firm’s evolutionary trajectory.
